Eli Lilly’s Zepbound outperforms Novo’s Wegovy in weight loss study
HQ team November 28, 2023: A recent comparative analysis of Eli Lilly and Novo Nordisk’s weight loss drugs on diabetes patients showed Eli.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ team November 28, 2023: A recent comparative analysis of Eli Lilly and Novo Nordisk’s weight loss drugs on diabetes patients showed Eli.
HQ Team November 28, 2023: Argenx SE, a Belgian biopharmaceutical announced that its experimental drug Vyvgart Hytrulo failed in trials in treating immune.
HQ Team November 24, 2023: A bacterium, staphylococcus aureus, single-handedly imbalances the equilibrium of micro-organisms, that keep the skin healthy, and cause itching,.
HQ Team November 24, 2023: One in five children and young people in England aged between eight and 25 had a probable mental.
HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France..
HQ Team November 23, 2023: The widely used disinfectant, bleach, commonly employed in hospitals for cleaning medical equipment and surfaces is ineffective against.
HQ Team November 23, 2023: A recent survey conducted by Northwestern University reveals diverse perspectives among patients and caregivers regarding the development of.
HQ Team November 22, 2023: Stanford researchers have developed a promising hydrogel-based delivery system that will potentially transform diabetes treatment. This innovative technology,.
HQ Team November 22, 2023: Tumour molecules can rob the human body’s immune cells to deprive them of their energy to fuel the.
HQ Team November 21, 2023: Zevra Therapeutics, Inc. has finalized its acquisition of Acer Therapeutics Inc in a $91m deal. This strategic acquisition.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com